408 related articles for article (PubMed ID: 18801471)
1. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
Raison CL; Borisov AS; Majer M; Drake DF; Pagnoni G; Woolwine BJ; Vogt GJ; Massung B; Miller AH
Biol Psychiatry; 2009 Feb; 65(4):296-303. PubMed ID: 18801471
[TBL] [Abstract][Full Text] [Related]
2. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
Raison CL; Borisov AS; Woolwine BJ; Massung B; Vogt G; Miller AH
Mol Psychiatry; 2010 May; 15(5):535-47. PubMed ID: 18521089
[TBL] [Abstract][Full Text] [Related]
4. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.
Felger JC; Alagbe O; Hu F; Mook D; Freeman AA; Sanchez MM; Kalin NH; Ratti E; Nemeroff CB; Miller AH
Biol Psychiatry; 2007 Dec; 62(11):1324-33. PubMed ID: 17678633
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
Felger JC; Li L; Marvar PJ; Woolwine BJ; Harrison DG; Raison CL; Miller AH
Brain Behav Immun; 2013 Jul; 31():153-60. PubMed ID: 23072726
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
Felger JC; Haroon E; Woolwine BJ; Raison CL; Miller AH
Physiol Behav; 2016 Nov; 166():14-21. PubMed ID: 26703235
[TBL] [Abstract][Full Text] [Related]
7. Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.
Felger JC; Alagbe O; Pace TW; Woolwine BJ; Hu F; Raison CL; Miller AH
Brain Behav Immun; 2011 Aug; 25(6):1094-8. PubMed ID: 21356304
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.
Lindqvist D; Janelidze S; Hagell P; Erhardt S; Samuelsson M; Minthon L; Hansson O; Björkqvist M; Träskman-Bendz L; Brundin L
Biol Psychiatry; 2009 Aug; 66(3):287-92. PubMed ID: 19268915
[TBL] [Abstract][Full Text] [Related]
10. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
11. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
Kenis G; Prickaerts J; van Os J; Koek GH; Robaeys G; Steinbusch HW; Wichers M
Int J Neuropsychopharmacol; 2011 Mar; 14(2):247-53. PubMed ID: 20667172
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
14. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
[TBL] [Abstract][Full Text] [Related]
15. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
Majer M; Welberg LA; Capuron L; Pagnoni G; Raison CL; Miller AH
Brain Behav Immun; 2008 Aug; 22(6):870-80. PubMed ID: 18258414
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
18. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
19. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular Administration of Interferon-Alpha Induced Depressive-Like Behaviors and Neurotransmitter Changes in Rhesus Monkeys.
Li Z; Li Z; Lv X; Li Z; Xiong L; Hu X; Qin D
Front Neurosci; 2020; 14():585604. PubMed ID: 33328856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
